カテゴリー： QYResearch, 世界, 医療/バイオ

ドフェティリドのグローバル市場2023年：カプセル、その他

◆英語タイトル：Global Dofetilide Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8742）◆商品コード：QYR23MA8742
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：88
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のドフェティリド市場について調査・分析し、世界のドフェティリド市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（カプセル、その他）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sigmapharm Laboratories、Mayne Pharma、Novadoz Pharmaceuticals、Pfizer、NorthStar Rx LLC、AvKARE, Inc.、Accord Healthcare、Bionpharma、Sun Pharmaceutical Industries Ltd.などが含まれています。世界のドフェティリド市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ドフェティリド市場規模を推定する際に考慮しました。

・ドフェティリド市場の概要
- 製品の定義
- ドフェティリドのタイプ別セグメント
- 世界のドフェティリド市場規模：タイプ別分析（カプセル、その他）
- ドフェティリドの用途別セグメント
- 世界のドフェティリド市場規模：用途別分析（病院、クリニック）
- 世界のドフェティリド市場規模予測（2018年-2029年）
- ドフェティリドの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ドフェティリド市場の競争状況およびトレンド

・ドフェティリドの地域別市場規模
- 北米のドフェティリド市場規模（2018年-2029年）
- アメリカのドフェティリド市場規模（2018年-2029年）
- ヨーロッパのドフェティリド市場規模（2018年-2029年）
- アジア太平洋のドフェティリド市場規模（2018年-2029年）
- 中国のドフェティリド市場規模（2018年-2029年）
- 日本のドフェティリド市場規模（2018年-2029年）
- 韓国のドフェティリド市場規模（2018年-2029年）
- インドのドフェティリド市場規模（2018年-2029年）
- オーストラリアのドフェティリド市場規模（2018年-2029年）
- 中南米のドフェティリド市場規模（2018年-2029年）
- 中東・アフリカのドフェティリド市場規模（2018年-2029年）

・タイプ別セグメント：カプセル、その他
- 世界のドフェティリドのタイプ別販売量（2018年-2023年）
- 世界のドフェティリドのタイプ別売上（2018年-2023年）
- 世界のドフェティリドのタイプ別価格

・用途別セグメント：病院、クリニック
- 世界のドフェティリドの用途別販売量（2018年-2023年）
- 世界のドフェティリドの用途別売上（2018年-2023年）
- 世界のドフェティリドの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Sigmapharm Laboratories、Mayne Pharma、Novadoz Pharmaceuticals、Pfizer、NorthStar Rx LLC、AvKARE, Inc.、Accord Healthcare、Bionpharma、Sun Pharmaceutical Industries Ltd.

・産業チェーンと販売チャネルの分析
- ドフェティリド産業チェーン分析
- ドフェティリドの主要原材料
- ドフェティリドの販売チャネル
- ドフェティリドのディストリビューター
- ドフェティリドの主要顧客

・ドフェティリド市場ダイナミクス
- ドフェティリドの業界動向
- ドフェティリド市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Dofetilide is a class III antiarrhythmic agent.
Highlights
The global Dofetilide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Dofetilide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Dofetilide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Dofetilide include Sigmapharm Laboratories, Mayne Pharma, Novadoz Pharmaceuticals, Pfizer, NorthStar Rx LLC, AvKARE, Inc., Accord Healthcare, Bionpharma and Sun Pharmaceutical Industries Ltd., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dofetilide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dofetilide.
The Dofetilide market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dofetilide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dofetilide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Sigmapharm Laboratories
Mayne Pharma
Novadoz Pharmaceuticals
Pfizer
NorthStar Rx LLC
AvKARE, Inc.
Accord Healthcare
Bionpharma
Sun Pharmaceutical Industries Ltd.
Segment by Type
Capsules
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dofetilide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dofetilide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Dofetilide Market Overview
1.1 Product Overview and Scope of Dofetilide
1.2 Dofetilide Segment by Type
1.2.1 Global Dofetilide Market Value Comparison by Type (2023-2029)
1.2.2 Capsules
1.2.3 Others
1.3 Dofetilide Segment by Application
1.3.1 Global Dofetilide Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dofetilide Market Size Estimates and Forecasts
1.4.1 Global Dofetilide Revenue 2018-2029
1.4.2 Global Dofetilide Sales 2018-2029
1.4.3 Global Dofetilide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dofetilide Market Competition by Manufacturers
2.1 Global Dofetilide Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dofetilide Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dofetilide Average Price by Manufacturers (2018-2023)
2.4 Global Dofetilide Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dofetilide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dofetilide, Product Type & Application
2.7 Dofetilide Market Competitive Situation and Trends
2.7.1 Dofetilide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dofetilide Players Market Share by Revenue
2.7.3 Global Dofetilide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dofetilide Retrospective Market Scenario by Region
3.1 Global Dofetilide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dofetilide Global Dofetilide Sales by Region: 2018-2029
3.2.1 Global Dofetilide Sales by Region: 2018-2023
3.2.2 Global Dofetilide Sales by Region: 2024-2029
3.3 Global Dofetilide Global Dofetilide Revenue by Region: 2018-2029
3.3.1 Global Dofetilide Revenue by Region: 2018-2023
3.3.2 Global Dofetilide Revenue by Region: 2024-2029
3.4 North America Dofetilide Market Facts & Figures by Country
3.4.1 North America Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dofetilide Sales by Country (2018-2029)
3.4.3 North America Dofetilide Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dofetilide Market Facts & Figures by Country
3.5.1 Europe Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dofetilide Sales by Country (2018-2029)
3.5.3 Europe Dofetilide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dofetilide Market Facts & Figures by Country
3.6.1 Asia Pacific Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dofetilide Sales by Country (2018-2029)
3.6.3 Asia Pacific Dofetilide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dofetilide Market Facts & Figures by Country
3.7.1 Latin America Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dofetilide Sales by Country (2018-2029)
3.7.3 Latin America Dofetilide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dofetilide Market Facts & Figures by Country
3.8.1 Middle East and Africa Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dofetilide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dofetilide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dofetilide Sales by Type (2018-2029)
4.1.1 Global Dofetilide Sales by Type (2018-2023)
4.1.2 Global Dofetilide Sales by Type (2024-2029)
4.1.3 Global Dofetilide Sales Market Share by Type (2018-2029)
4.2 Global Dofetilide Revenue by Type (2018-2029)
4.2.1 Global Dofetilide Revenue by Type (2018-2023)
4.2.2 Global Dofetilide Revenue by Type (2024-2029)
4.2.3 Global Dofetilide Revenue Market Share by Type (2018-2029)
4.3 Global Dofetilide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dofetilide Sales by Application (2018-2029)
5.1.1 Global Dofetilide Sales by Application (2018-2023)
5.1.2 Global Dofetilide Sales by Application (2024-2029)
5.1.3 Global Dofetilide Sales Market Share by Application (2018-2029)
5.2 Global Dofetilide Revenue by Application (2018-2029)
5.2.1 Global Dofetilide Revenue by Application (2018-2023)
5.2.2 Global Dofetilide Revenue by Application (2024-2029)
5.2.3 Global Dofetilide Revenue Market Share by Application (2018-2029)
5.3 Global Dofetilide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sigmapharm Laboratories
6.1.1 Sigmapharm Laboratories Corporation Information
6.1.2 Sigmapharm Laboratories Description and Business Overview
6.1.3 Sigmapharm Laboratories Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sigmapharm Laboratories Dofetilide Product Portfolio
6.1.5 Sigmapharm Laboratories Recent Developments/Updates
6.2 Mayne Pharma
6.2.1 Mayne Pharma Corporation Information
6.2.2 Mayne Pharma Description and Business Overview
6.2.3 Mayne Pharma Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mayne Pharma Dofetilide Product Portfolio
6.2.5 Mayne Pharma Recent Developments/Updates
6.3 Novadoz Pharmaceuticals
6.3.1 Novadoz Pharmaceuticals Corporation Information
6.3.2 Novadoz Pharmaceuticals Description and Business Overview
6.3.3 Novadoz Pharmaceuticals Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novadoz Pharmaceuticals Dofetilide Product Portfolio
6.3.5 Novadoz Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Dofetilide Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 NorthStar Rx LLC
6.5.1 NorthStar Rx LLC Corporation Information
6.5.2 NorthStar Rx LLC Description and Business Overview
6.5.3 NorthStar Rx LLC Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NorthStar Rx LLC Dofetilide Product Portfolio
6.5.5 NorthStar Rx LLC Recent Developments/Updates
6.6 AvKARE, Inc.
6.6.1 AvKARE, Inc. Corporation Information
6.6.2 AvKARE, Inc. Description and Business Overview
6.6.3 AvKARE, Inc. Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AvKARE, Inc. Dofetilide Product Portfolio
6.6.5 AvKARE, Inc. Recent Developments/Updates
6.7 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Accord Healthcare Dofetilide Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Bionpharma
6.8.1 Bionpharma Corporation Information
6.8.2 Bionpharma Description and Business Overview
6.8.3 Bionpharma Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bionpharma Dofetilide Product Portfolio
6.8.5 Bionpharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Ltd. Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharmaceutical Industries Ltd. Dofetilide Product Portfolio
6.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dofetilide Industry Chain Analysis
7.2 Dofetilide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dofetilide Production Mode & Process
7.4 Dofetilide Sales and Marketing
7.4.1 Dofetilide Sales Channels
7.4.2 Dofetilide Distributors
7.5 Dofetilide Customers
8 Dofetilide Market Dynamics
8.1 Dofetilide Industry Trends
8.2 Dofetilide Market Drivers
8.3 Dofetilide Market Challenges
8.4 Dofetilide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ドフェティリドのグローバル市場2023年：カプセル、その他(Global Dofetilide Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 下垂体サプリメントのグローバル市場2023年：カプセル、錠剤
  • 新型コロナ抗ウイルス経口薬品のグローバル市場2023年：錠剤、カプセル
  • 高麗人参サプリメントのグローバル市場2023年：カプセル、錠剤、液剤

    • ◆H&Iグローバルリサーチのお客様（例）◆